Image: The system-on-chip is designed to yield highly-secure molecular data, which can be used in the recognition and analysis of health threats caused by pathogens and other living organisms (Photo courtesy of Nano Global).
The chip, combined with the company’s scientific technology platform, leverages advances in nanotechnology, optics, artificial intelligence (AI), blockchain authentication, and edge computing to access and analyze molecular-level data in real time. The initial development of the chip is underway and the first delivery is expected by 2020, with the company having already begun adding new partners to their platform.
“In partnership with Arm, we’re tackling the vast frontier of molecular data to unlock the unlimited potential of this universe,” said Steve Papermaster, Chairman and CEO of Nano Global. “The data our technology can acquire and process will enable us to create a safer and healthier world.”
“We believe the technology Nano Global is delivering will be an important step forward in the collective pursuit of care that improves lives through the application of technology,” said Rene Haas, executive vice president and president of IPG, Arm. “By collaborating with Nano Global, Arm is taking an active role in developing and deploying the technologies that will move us one step closer to solving complex health challenges.”
Nano Global will also be partnering with several leading institutions, including Baylor College of Medicine and National University of Singapore, on broad research initiatives in clinical, laboratory, and population health environments to accelerate data collection, analysis, and product development.